معرفی
Roman A. Melnyk is a Professor in the Department of Biochemistry at the University of Toronto, with research focused on bacterial toxin pathogenesis and drug discovery. His work integrates chemical biology, molecular biophysics, and structural analysis to study bacterial toxins' mechanisms and develop therapeutic interventions.
Research Interests: Drug discovery targeting bacterial toxins, biophysics of membrane protein transport, and engineering toxin-delivery platforms for non-cell-penetrant therapeutics. His studies address diseases caused by pathogens like Clostridium difficile and HIV-1, leveraging toxin biology for both inhibition and delivery applications.
Scientific Awards:
- 2014 — Early Researcher Award, Ontario Ministry of Economic Development & Innovation
Research Trends: Recent publications emphasize structural insights into toxin pores, small-molecule antivirulence strategies, and repurposing bacterial toxins for therapeutic delivery. Key subfields include C. difficile pathogenesis, HIV-1 reverse transcriptase inhibition, and computational modeling of toxin-host interactions.
Labs & Collaborations: Melnyk leads a research lab at the University of Toronto, collaborating with institutions such as SickKids and Vanderbilt University. His work spans interdisciplinary areas including microbiology, pharmacology, and structural biology.
